Thrombin Inhibitor in Venous Thromboembolism - THRIVE

Description:

The goal of this trial was to evaluate the efficacy of ximelagatran compared with enoxaparin/warfarin treatment for the prevention of recurrent venous thromboembolism after six months of anticoagulant therapy among patients with acute deep vein thrombosis.